BioUtah, the trade association, common voice, and flag bearer for Utah's life sciences industry, will participate in the 2025 J.P. Morgan 43rd Annual Healthcare Conference. BioUtah to co-host an RSVP-required reception on Sunday night,

The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website here. OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large,

To access the live webcast or subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at About RAPT Therapeutics, Inc. RAPT Therapeutics is a clinical-stage,

ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced that Chairman and Chief Executive Officer, David Hallal,

Institutional investors interested in meeting with management during the conference may reach out to their J.P. Morgan representatives. About Solid Biosciences Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy (Duchenne),

Emergent BioSolutions (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world​, today announced